The Global Proteomics Market was valued at USD 41.2 billion in 2025 and is estimated to grow at a CAGR of 12% to reach USD 126.3 billion by 2035.
Proteomics encompasses the study of proteins within biological systems, including their identification, quantification, and functional analysis. Tools in this market include mass spectrometry platforms, protein microarrays, and label-free quantification systems that support high-throughput protein profiling. Rapid advancements in technology and the integration of AI and machine learning into proteomic workflows are driving market expansion. The rise of single-cell proteomics is revolutionizing research by enabling protein analysis at the individual cell level, providing deep insights into tumor heterogeneity, disease progression, and immune system dynamics. These advances are not only transforming research but are also making proteomics increasingly applicable in clinical diagnostics. Modern high-throughput systems continue to improve sensitivity, speed, and accuracy, enhancing data quality for large-scale studies and accelerating precision medicine development worldwide.
The consumables and reagents segment accounted for 69.4% share in 2025 and is projected to grow at a CAGR of 12.3%. This segment includes protein chips, assay kits, reagents, buffers, chromatography columns, and electrophoresis gels, which are repeatedly used in mass spectrometry, chromatography, and microarray analyses, ensuring recurring revenue.
The advanced techniques segment reached USD 21.6 billion in 2025. This category includes mass spectrometry, protein microarrays, gel-based techniques, and other advanced methods. These approaches provide superior sensitivity, precision, and throughput compared to conventional methods, driving innovation in research, clinical diagnostics, drug development, and personalized therapies.
North America Proteomics Market reached USD 19.9 billion in 2025 and is projected to reach USD 61.9 billion by 2035, at a CAGR of 12.2%. Growth in the region is fueled by strong biomedical research infrastructure, rapid technology adoption, and an advanced healthcare ecosystem. The integration of AI and machine learning for data analysis, alongside collaboration among academic institutions, biotech firms, and pharmaceutical companies, is accelerating protein profiling, biomarker development, and precision medicine applications.
Key players in the Global Proteomics Market include Agilent Technologies, Biognosys, Bio-Rad, Bruker, Creative Proteomics, F. Hoffmann-La Roche, Merck KGaA, PREOMICS, Promega, Quantum-Si, Seer, SomaLogic, Thermo Fisher Scientific (Olink), and Waters. Companies in the Proteomics Market are strengthening their position by investing heavily in R&D to improve the sensitivity, accuracy, and throughput of proteomics platforms. They are forming strategic partnerships with academic institutions, pharmaceutical firms, and biotech startups to expand their service offerings and enhance collaborative innovation. Firms are also integrating AI and machine learning to streamline workflows and generate actionable insights from large proteomic datasets. Additionally, they are launching comprehensive consumable and reagent portfolios to ensure recurring revenue, expanding geographically to capture emerging markets, and participating in clinical validation programs to support regulatory approvals and adoption in clinical diagnostics.
This product will be delivered within 2-4 business days.
Proteomics encompasses the study of proteins within biological systems, including their identification, quantification, and functional analysis. Tools in this market include mass spectrometry platforms, protein microarrays, and label-free quantification systems that support high-throughput protein profiling. Rapid advancements in technology and the integration of AI and machine learning into proteomic workflows are driving market expansion. The rise of single-cell proteomics is revolutionizing research by enabling protein analysis at the individual cell level, providing deep insights into tumor heterogeneity, disease progression, and immune system dynamics. These advances are not only transforming research but are also making proteomics increasingly applicable in clinical diagnostics. Modern high-throughput systems continue to improve sensitivity, speed, and accuracy, enhancing data quality for large-scale studies and accelerating precision medicine development worldwide.
The consumables and reagents segment accounted for 69.4% share in 2025 and is projected to grow at a CAGR of 12.3%. This segment includes protein chips, assay kits, reagents, buffers, chromatography columns, and electrophoresis gels, which are repeatedly used in mass spectrometry, chromatography, and microarray analyses, ensuring recurring revenue.
The advanced techniques segment reached USD 21.6 billion in 2025. This category includes mass spectrometry, protein microarrays, gel-based techniques, and other advanced methods. These approaches provide superior sensitivity, precision, and throughput compared to conventional methods, driving innovation in research, clinical diagnostics, drug development, and personalized therapies.
North America Proteomics Market reached USD 19.9 billion in 2025 and is projected to reach USD 61.9 billion by 2035, at a CAGR of 12.2%. Growth in the region is fueled by strong biomedical research infrastructure, rapid technology adoption, and an advanced healthcare ecosystem. The integration of AI and machine learning for data analysis, alongside collaboration among academic institutions, biotech firms, and pharmaceutical companies, is accelerating protein profiling, biomarker development, and precision medicine applications.
Key players in the Global Proteomics Market include Agilent Technologies, Biognosys, Bio-Rad, Bruker, Creative Proteomics, F. Hoffmann-La Roche, Merck KGaA, PREOMICS, Promega, Quantum-Si, Seer, SomaLogic, Thermo Fisher Scientific (Olink), and Waters. Companies in the Proteomics Market are strengthening their position by investing heavily in R&D to improve the sensitivity, accuracy, and throughput of proteomics platforms. They are forming strategic partnerships with academic institutions, pharmaceutical firms, and biotech startups to expand their service offerings and enhance collaborative innovation. Firms are also integrating AI and machine learning to streamline workflows and generate actionable insights from large proteomic datasets. Additionally, they are launching comprehensive consumable and reagent portfolios to ensure recurring revenue, expanding geographically to capture emerging markets, and participating in clinical validation programs to support regulatory approvals and adoption in clinical diagnostics.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Component, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Technique, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies profiled in this Proteomics market report include:- Agilent Technologies
- Biognosys
- Bio-Rad
- Bruker
- Creative Proteomics
- F. Hoffmann-La Roche
- Merck KGaA
- PREOMICS
- Promega
- Quantum-Si
- Seer
- SomaLogic Operating
- Thermo Fisher Scientific (Olink)
- Waters
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | February 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 41.2 Billion |
| Forecasted Market Value ( USD | $ 126.3 Billion |
| Compound Annual Growth Rate | 12.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
